Milmed Unico AB
Early-stage developer of patented medicinal probiotics for chronic diseases.
Oversigt
- 1–4
- Medarbejdere
- 100–149t SEK
- Omsætning
- 2018
- Grundlagt
Beskrivelse
Milmed Unico AB is an early-stage biotechnology company focused on developing groundbreaking medicinal probiotics. Their core technology is based on a patented, non-toxic yeast culture that has shown positive impacts on living cells. The company holds patent protection for treatments targeting three...